title: High success rate of atrioventricular node ablation with radiofrequency energy.
abstract: Radiofrequency current was introduced as an alternative energy source for transcatheter ablation of cardiac arrhythmias to avoid the complications associated with direct current shocks. Initial use of radiofrequency current for complete ablation of the atrioventricular (AV) node yielded only moderate success rates, presumably because of the small size of electrodes and difficulty in localizing the AV node. The use of a larger 4-mm tip electrode for delivery of radiofrequency current and a method to better localize the AV node were prospectively studied in 32 patients undergoing catheter ablation of the AV node. There were 21 men and 11 women with a mean age of 62 +/- 12 years. Complete AV block was achieved immediately in 31 patients (97%) and it persisted in 28 patients (88%) during a mean follow-up period of 12 +/- 6 months. Three patients who had return of AV condition required no drug therapy for control of ventricular rate during atrial fibrillation. The number of radiofrequency pulses used to achieve complete AV block ranged from 1 to 5 (mean 1.9 +/- 1.1). In greater than 50% of the cases, only one radiofrequency pulse was required. The mean power and duration of radiofrequency pulses were 21.2 +/- 4.5 W and 33 +/- 15 s, respectively. All patients developed a stable junctional escape rhythm within 45 min of successful ablation. The QRS configuration was unchanged in 30 patients. One patient had a new right bundle branch block after ablation. There were no complications related to the ablation procedure.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: University Hospital, University of British Columbia, Department of Medicine, Vancouver, Canada.
authors.forename: J A
authors.initials: JA
authors.lastname: Yeung-Lai-Wah
authors.forename: J F
authors.initials: JF
authors.lastname: Alison
authors.forename: L
authors.initials: L
authors.lastname: Lonergan
authors.forename: R
authors.initials: R
authors.lastname: Mohama
authors.forename: R
authors.initials: R
authors.lastname: Leather
authors.forename: C R
authors.initials: CR
authors.lastname: Kerr
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery*; D001283:Atrioventricular Node / Q000601:surgery*; D004562:Electrocardiography; D004564:Electrocoagulation / Q000379:methods / Q000592:standards*; D004594:Electrophysiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011846:Radio Waves; D011859:Radiography; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery*; D013612:Tachycardia, Ectopic Atrial / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents